A PHASE-II STUDY OF ORAL ETOPOSIDE IN ELDERLY PATIENTS WITH SMALL CELL LUNG-CANCER

被引:77
作者
SMIT, EF
CARNEY, DN
HARFORD, P
SLEIJFER, DT
POSTMUS, PE
机构
[1] STATE UNIV GRONINGEN HOSP,DEPT PULM DIS,OOSTERSINGEL 59,9713 EZ GRONINGEN,NETHERLANDS
[2] STATE UNIV GRONINGEN HOSP,DEPT INTERNAL MED,DIV MED ONCOL,9713 EZ GRONINGEN,NETHERLANDS
[3] ST LUKES HOSP,DUBLIN,IRELAND
关键词
D O I
10.1136/thx.44.8.631
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页码:631 / 633
页数:3
相关论文
共 13 条
[1]  
ALLAN SG, 1984, CANCER CHEMOTH PHARM, V13, P106
[2]  
CAVALLI F, 1984, ETOPOSIDE VP16 CURRE, P163
[3]  
Ihde D C, 1984, Cancer, V54, P2722, DOI 10.1002/1097-0142(19841201)54:2+<2722::AID-CNCR2820541419>3.0.CO
[4]  
2-P
[5]  
KREYBORG C, 1969, THESIS OSLO
[6]   VINCRISTINE AND ETOPOSIDE - AN EFFECTIVE CHEMOTHERAPY REGIMEN WITH REDUCED TOXICITY IN EXTENSIVE SMALL-CELL LUNG-CANCER [J].
MORGAN, DAL ;
GILSON, D ;
FLETCHER, J .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (06) :619-621
[7]  
POPLIN E, 1987, CANCER TREAT REP, V71, P291
[8]  
SAMET J, 1986, JAMA-J AM MED ASSOC, V225, P3385
[9]  
SLEVIN ML, 1986, P ASCO
[10]  
STEWART DJ, 1985, CANCER TREAT REP, V69, P269